Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial ABSTRACT Background: Jejunal feeding is preferred instead of gastric feeding in patients who are intolerant to gastric feeding or at risk of aspiration. However, the impact of gastric feeding compared with that of jejunal feeding on postprandial circulating plasma glucose and amino acid concentrations and the associated endocrine response in vivo in humans remains largely unexplored. Objective: We compared the impact of administering enteral nutrition as either gastric feeding or jejunal feeding on endocrine responses in vivo in humans. Design: In a randomized, crossover study design, 12 healthy young men (mean 6 SD age: 21 6 2 y) received continuous enteral nutrition that contained noncoagulating proteins for 12 h via a nasogastric tube or a nasojejunal tube placed 30-40 cm distal to the ligament of Treitz. Blood samples were collected during the 12-h postprandial period to assess the rise in plasma glucose, amino acid, and gastrointestinal hormone concentrations. Results: No differences were observed in the postprandial rise in circulating plasma amino acid and glucose concentrations between regimens. Jejunal feeding resulted in higher peak plasma insulin concentrations than did gastric feeding (392 6 53 compared with 326 6 54 pmol/L, respectively; P , 0.05). The postprandial rise in plasma cholecystokinin, peptide YY (PYY), glucagon-like peptide 1 (GLP-1), and glucagon-like peptide 2 (GLP-2) concentrations was greater after jejunal feeding than after gastric feeding, with higher peak concentrations and a greater postprandial incremental AUC for GLP-1 and cholecystokinin (all P , 0.05). Plasma ghrelin concentrations did not differ between regimens. Conclusions: Enteral nutrition with gastric or jejunal feeding in healthy young men results in similar postprandial plasma amino acid and glucose concentrations. However, the endocrine response differs substantially, with higher peak plasma cholecystokinin, PYY, GLP-1, and GLP-2 concentrations being attained after jejunal feeding. This effect may result in an improved anabolic response, greater insulin sensitivity, and an improved intestinotropic effect. Nevertheless, it may also lead to delayed gastric emptying. This trial was registered at trialregister.nl as NTR2801. Am J Clin Nutr 2016;103:435-43.
INTRODUCTION
Malnutrition has a reported prevalence rate as high as 50% in hospitalized patients (1) . The negative impact caused by malnutrition in the hospital setting has been shown to increase morbidity, mortality, and the length of hospital stay, and, as a consequence, associated costs (2, 3) . Patients have metabolic and immune neuroendocrine derangements that are exacerbated by energy and protein deficits that occur during the early stages of admission to the intensive care unit (4) . The treatment of critically ill patients has become more focused on nutrition therapy, specifically with attempts to attenuate the metabolic response to stress, prevent oxidative cellular injury, and favorably modulate the immune response (5) .
Because parenteral feeding has been associated with a greater incidence of infectious complications and increased mortality (6) , enteral nutrition (EN) 11 is the preferred route of feeding for critically ill patients who require nutritional support therapy (5) . Moreover, EN preserves the intestinal integrity and prevents mucosal atrophy and bacterial translocation (7, 8) . There are several different methods of administering EN of which gastric tube feeding is the most-commonly applied route of access. However, the administration of EN via the gastric route in patients suffering from bowel-motility disorders may lead to high gastric residual volumes and, consequently, to pulmonary aspiration (9) . These problems can be overcome by inserting a jejunal feeding tube. Metheny et al. (10) observed 18% lower aspiration when the feeding tube was placed in at least the fourth portion of the duodenum. Previous research in patients after a gastrectomy or Roux-en-Y gastric bypass (RYGB) indicated that bypassing or eliminating the stomach does not per se lead to malabsorption (11, 12) . After operation-associated metabolic sequelae have resolved, there is no evidence that exclusive jejunal feeding results in protein malnutrition (13) . However, bypassing the stomach and the duodenum obviates important endocrine and exocrine functions of these organs. Knowledge of the effect of the site of EN delivery on gastrointestinal hormones is crucial, especially for critically ill patients because of their altered hormone response and delayed gastric emptying. This study will give us insight on whether, during the continuous administration of EN, the site of nutrient delivery affects the magnitude of gastrointestinal hormone secretion in response to nutrients.
Thus, the aim of this study was to compare the impact of gastric compared with jejunal administration of EN on circulating plasma glucose and amino acids concentrations and the associated endocrine response in vivo in humans. With the administration of polymeric EN and frequent blood sampling, we compared the impact of gastric feeding with that of jejunal feeding on gastrointestinal hormone responses and nutrient digestion and absorption in 12 healthy young men.
METHODS

Subjects
Twelve healthy men (mean 6 SD age: 21 6 2 y) participated in the current study. Subjects were randomly assigned to either a gastric-jejunal or jejunal-gastric treatment sequence in a crossover design. Inclusion criteria were as follows: age between 18 and 45 y, BMI (in kg/m 2 ) between 18 and 27, no use of medication, nonsmoking, no abnormalities on a general physical examination, and basic blood results within the respective reference ranges. One subject dropped out before the start of the study because of a vasovagal reaction on blood withdrawal. Subject characteristics are presented in Table 1 .
The trial was carried out at a university-based hospital (Kennemer Gasthuis, Haarlem, Netherlands) to evaluate the effects of 2 regimens of nutritional support on subsequent protein digestion and amino acid absorption of intact casein. All subjects were informed of the nature and possible risk of the experimental procedures before the written informed consent of subjects was obtained. The study was carried out after the receipt of international ethical approval by the Medical Ethical Committee of Noord-Holland, Alkmaar, Netherlands. This trial was registered at trialregister.nl as NTR2801.
Diet and physical activity before testing
All volunteers were instructed to refrain from alcohol consumption and exhaustive physical activity and to keep a constant diet 3 d before the trial. All subjects consumed a standardized meal the day before the experiment.
Experiment
According to a crossover design, each subject received EN through a nasogastric tube (NGT) and a nasojejunal tube (NJT), each of which were separated by a $4-wk washout period. In healthy subjects with normal small intestinal motility, NJTs, once they are correctly positioned in the stomach, will migrate in a caudad direction during the phase III migrating motor complex. Abdominal X-rays were performed to confirm that the NGTs were correctly positioned in the stomach (Supplemental Material 1), and the NJT was w30-40 cm distal to the ligament of Treitz (Supplemental Material 2).
Protocol
After an overnight fast, a polyurethane catheter was placed in a dorsal hand vein for frequent blood sampling. The administration of the EN through an NGT or NJT was started directly after basal blood sampling. Venous blood samples were collected frequently during a 12-h postprandial period at 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 480, and 720 min. Venous blood glucose analyses were performed immediately. Blood samples were collected into EDTA-containing tubes, serum tubes, heparin tubes, and P800 tubes (K 2 EDTA Tube with a proprietary cocktail of protease, esterase, and dipeptidyl peptidase -IV inhibitors; BD Diagnostics), and centrifuged within 10 min after sampling at 1770 3 g for 12 min at 48C. Aliquots of plasma were frozen and stored at -808C. FIGURE 1 Mean 6 SEM plasma glucose (A), insulin (B), and C-peptide (C) concentrations after either gastric feeding (n = 11) or jejunal feeding (n = 12). Data were analyzed with the use of a repeated-measures mixed-model ANOVA. There was no significant difference between regimens.
TABLE 3
Plasma glucose, insulin, and C-peptide concentrations: baseline, peak value, time to peak, iAUC, and insulinogenic index after either gastric feeding (n = 11) or jejunal feeding (n = 12 
EN
The amount of EN was determined with the use of the HarrisBenedict equation with the stress factor none and the activity factor bed rest (14) . For healthy male subjects with minimal activity the basal energy expenditure can be estimated with the Harris-Benedict equation multiplied by 1.3 as follows (15) Table 2 ).
Plasma analysis
Plasma glucose concentrations were analyzed with the HemoCue Glucose 201 DM Analyzer (HemoCue Diagnostics BV). After the precipitation of proteins and polypeptides with perchloric acid, the plasma samples were centrifuged, and the clear supernatant fluid was collected. Plasma amino acid concentrations were measured with the use of HPLC after precolumn derivatization with o-phtaldialdehyde and fluorimetry (Nutricia Research). Plasma insulin, C-peptide, cholecystokinin, plasma peptide YY (PYY ), and ghrelin were determined by the Department of Clinical Chemistry, VU University Medical Center, Amsterdam, Netherlands. Plasma insulin and C-peptide concentrations were analyzed with the use of a luminescence immunometric assay (Advia Centaur; Siemens Medical Solutions Diagnostics). Cholecystokinin concentrations were analyzed with the use of a radioimmunoassay (Euro-Diagnostica). PYY concentrations were analyzed with the use of a radioimmunoassay (Millipore). Plasma ghrelin concentrations were analyzed with the use of a radioimmunoassay (Linco Research Inc.). Glucagon-like peptide 1 (GLP-1) and glucagon-like peptide 2 (GLP-2) concentrations in plasma were measured with the use of radioimmunoassays after the extraction of plasma with 70% ethanol (volume:volume; final concentration). Carboxyterminal GLP-1 immunoreactivity was determined with the use of antiserum 89390, which has an absolute requirement for the intact amidated carboxy-terminus of GLP-1-(7-36) amide and crossreacts ,0.01% with carboxy-terminally truncated fragments and 89% with GLP-1-(9-36) amide (16) . GLP-2 concentrations were measured with the use of a radioimmunoassay with antiserum code 92160 and standards of human GLP-2 (proglucagon 126-158; Novo Nordisk A/S) and monoiodinated Tyr-12 GLP-1 (specific activity .70 MBq/nmol) (17) . The antiserum was directed against the N-terminus of GLP-2 and, therefore, measured only fully processed GLP-2 of intestinal origin. The sensitivity for both assays was ,5 pmol/L, and the intra-assay CV was ,10%.
Statistics
This was an exploratory study; to our knowledge, the primary variables have not been previously reported in healthy subjects or patients. Therefore, the expected difference between the study groups and its variance were estimates that were based on the results published by Ledeboer et al. (18, 19) . They studied a comparable group of healthy subjects; however, they compared gastric feeding with duodenal feeding, whereas in the current study, gastric feeding was compared with jejunal feeding. Differences in the hormone response of cholecystokinin on 2 time points (20 and 240 min) reported by Ledeboer et al. (18, 19) were FIGURE 2 Mean 6 SEM sum of all plasma AAs (A), EAAs (B), phenylalanine (C), and leucine (D) concentrations after either gastric feeding (n = 11) or jejunal feeding (n = 12). Data were analyzed with the use of a repeated-measures mixed-model ANOVA. P-interaction of time and treatment , 0.01. *Significantly different from jejunal feeding, P , 0.05. AA, amino acid; EAA, essential amino acid.
used to calculate the expected difference in the change between gastric feeding and jejunal feeding. On the basis of these data, it was assumed that the expected mean difference in the change of cholecystokinin after 20 min of the administration of EN between gastric feeding and jejunal feeding for cholecystokinin was w3.3 pmol/L (6.6 compared with 3.3 pmol/L, respectively). The within-group SD of the change was expected to be between 0.7 and 2.4 pmol/L (on the basis of a correlation of r = 0.8 between gastric feeding and jejunal feeding). With the application of a significance level (a) of 0.050, a paired t test, and a power of 80%, the proposed sample size of 5 was thought to be sufficient to detect a relevant difference between groups.
It was assumed that the expected mean difference in the change of cholecystokinin after 240 min of the administration of EN between gastric feeding and jejunal feeding for cholecystokinin was w0.8 pmol/L (3.7 compared with 2.9 pmol/L, respectively). The within-group SD of the change was expected to be between 1.0 and 1.2 (on the basis of a correlation of r = 0.8 between gastric feeding and jejunal feeding). With the application of a significance level (a) of 0.050, a paired t test, and a power of 80%, the proposed sample size of 9 was thought to be sufficient to detect a significant result between groups.
With the use of these estimates, a significance level (a) of 0.05, and a power of 80%, a sample size of n = 9 was assumed to detect a significant difference with the use of the Statpower program version 2.0 (Scientific Software Inc.) (20, 21) . With the assumption of a 20% dropout, a total of 12 subjects were needed.
Baseline characteristics are expressed as means 6 SDs, and P values were based on Student's t test for independent samples. All efficacy data are expressed as means 6 SEMs. The mean time to peak was calculated from every subject's specific time to peak. Efficacy variable P values were based on a repeatedmeasures mixed-model ANOVA with the treatment, period, and sequence as fixed factors and the subject as a random factor. The P value of the within-time analysis to compare differences between treatments over time was based on a repeated-measures mixed-model ANOVA with the treatment, period, sequence, time, and time$treatment interaction as fixed factors and the subject as a random factor. For variables with ordered or ordinal categories, the Wilcoxon's signed rank test was used, and binomial variables were analyzed with the use of the McNemar's test. Statistical significance was set at P , 0.05. All calculations were performed by Nutricia Research Utrecht with the use of SAS (SAS Enterprise Guide 4.3 or higher) for Windows software (SAS Institute Inc.).
RESULTS
Plasma glucose, insulin, and C-peptide
Results of the analysis of plasma glucose, insulin, and C-peptide are shown in Figure 1 and Table 3 . Plasma glucose concentrations increased immediately after the onset of EN administration in both groups. The time to peak, peak value, and incremental AUC (iAUC) of plasma glucose concentrations did not differ significantly between regimens. Plasma insulin concentrations increased rapidly in both groups and reached peak concentrations of 174 6 68 min and 162 6 63 min, respectively. Peak plasma insulin concentrations were significantly higher TABLE 4 Plasma amino acid concentrations: baseline, peak value, time to peak, and iAUC after either gastric feeding (n = 11) or jejunal feeding (n = 12) All values are means 6 SEMs. There was no significant difference between regimens. AA, amino acid; EAA, essential amino acid; iAUC, incremental AUC; NGT, nasogastric tube; NJT, nasojejunal tube.
after jejunal feeding than after gastric feeding. The insulinogenic index (ratio of the insulin concentration at 30 min minus fasting insulin to the difference of glucose at the same time) showed no significant difference between regimens. C-peptide concentrations were not different between groups. Significant correlations were observed between peak insulin and peak C-peptide concentrations after gastric feeding (r = 0.84, P , 0.05) and after jejunal feeding (r = 0.85, P , 0.05).
Plasma amino acids
Results of the analysis of plasma amino acids are shown in Figure 2 and Table 4 . The time to peak, peak value, and iAUC of the sum of all amino acids, sum of all essential amino acids, phenylalanine, leucine, glutamine, and citrulline did not differ between feeding regimens. The within-time analysis showed significantly higher concentrations for the sum of all amino acids and phenylalanine at 45 and 60 min after jejunal feeding than after gastric feeding. The within-time analysis also showed significantly higher concentrations for glutamine at 45 min and, for citrulline, at 210 min after gastric feeding than after jejunal feeding.
Gastrointestinal hormones
Results of the analysis of gastrointestinal hormones are shown in Figure 3 and Table 5 . Peak plasma cholecystokinin concentrations were significantly higher after jejunal feeding (12 6 2 pmol/L) than after gastric feeding (4 6 2 pmol/L; P , 0.05). The iAUC was significantly higher after jejunal feeding (2551 6 542 pmol/L) than after gastric feeding (907 6 574 pmol/L; P , 0.05). The time to peak was not different between groups; however, cholecystokinin concentrations were significantly higher at 30, 90, 120, 180, and 480 min after jejunal feeding.
Peak plasma PYY concentrations were higher after jejunal feeding (81 6 7 pg/mL) than after gastric feeding (65 6 7 pg/mL; P , 0.05). The time to peak and iAUC were not significantly different; however, PYY concentrations were significantly higher at 30, 60, 120, 150, 180, 210, 240, and 480 min after jejunal feeding. Plasma ghrelin concentrations declined similarly after EN administration in both feeding regimens. The times to peak, peak values, and iAUCs were also similar.
Peak plasma GLP-1 concentrations were significantly higher after jejunal feeding (22 6 1 pmol/L) than after gastric feeding (17 6 1 pmol/L; P , 0.05). The iAUC was significantly higher after jejunal feeding (2212 6 371 pmol/L) than after gastric feeding (1033 6 574 pmol/L; P , 0.05). The time to peak was not different between groups; however, GLP-1 concentrations were significantly higher at 60, 480, and 720 min after jejunal feeding.
Peak plasma GLP-2 concentrations were significantly higher after jejunal feeding (24 6 2 pmol/L) than after gastric feeding (17 6 2 pmol/L; P , 0.05). The iAUC and time to peak were not different between groups; however, GLP-2 concentrations were significantly higher at 30, 90, 120, and 480 min after jejunal feeding.
Significant correlations were observed between peak values of plasma cholecystokinin and PYY concentrations after gastric feeding (r = 0.66, P , 0.05). Peak values of plasma cholecystokinin and ghrelin concentrations were correlated inversely with each other after jejunal feeding (r = 20.75, P , 0.05).
Safety and tolerance
A data-safety monitoring board was installed before the first subject was enrolled to ensure an ongoing evaluation of the serious adverse events that might have occurred during the study. No serious adverse events were reported. A total of 3 adverse events were possibly related to the administration of intact casein of which one event was reported with gastric feeding (occurring in one subject because of nausea) and 2 events with jejunal feeding (occurring in one subject because of nausea and in one subject because of diarrhea). The number of adverse events was not significantly different between groups. Blood safety variables all remained within the respective reference ranges, and no clinically relevant changes in liver and kidney function were observed (data not shown).
DISCUSSION
In the current study, we compared the impact of gastric administration compared with jejunal administration of EN on circulating plasma glucose and amino acids concentrations and the associated endocrine response in vivo in humans. Noncoagulating polymeric EN did not result in different postprandial plasma amino acid and glucose concentrations between regimens. However, the postprandial endocrine response after the administration of EN differed substantially between jejunal feeding and gastric feeding in healthy men, with higher peak plasma cholecystokinin, PYY, GLP-1, and GLP-2 concentrations after jejunal feeding.
In patients with gastric retention, nasogastric feeding is contraindicated and introduces risks of regurgitation and pulmonary aspiration; jejunal feeding is an alternative route. Studies have suggested that jejunal feeding requires a predigested diet rather than a polymeric diet (22) (23) (24) . This suggestion is in contrast with the result of our study in which we administer polymeric EN and showed a similar postprandial rise in circulating plasma amino acid concentrations between regimens. These results imply that adequate nutrition support can be obtained with jejunal feeding. These results are also in contrast with the phenomenon of the ileal brake, which is thought to be activated by the infusion of polymeric EN distal to the ligament of Treitz, causing the release of PYY and GLP-1. PYY inhibits exocrine pancreatic secretion, which leads to a reduced absorption. In our study, we also observed higher peak plasma PYY and GLP-1 concentrations after jejunal feeding distal to the ligament of Treitz; nevertheless, jejunal feeding did not lead to a reduced digestion and absorption of nutrients as was suggested by other authors (22) . In our opinion, the composition of EN determines the nutrient digestion and absorption to a greater extent than does the gastrointestinal endocrine response in which the proportion of casein is crucial for the EN to not coagulate in the acidic environment of the stomach (25) . In our previous study we showed that jejunal feeding with labeled casein was followed by more-rapid protein digestion and amino acid absorption than what was achieved with gastric feeding (26) . Thus, predigestion by gastric acid does not seem to be required for pancreatic proteases to effectively degrade the proteins and, therefore, to result in a similar rise in postprandial amino acid concentration with gastric feeding and jejunal feeding. Compared with gastric feeding, continuous jejunal feeding does not lead to differences in the rise in circulating citrulline and glutamine; which suggests that, in both feeding regimens, there is an active intestinal enterocyte metabolic mass with access to postprandial glutamine. Moreover, the higher concentrations of the intestinotropic hormone GLP-2 after jejunal feeding than after gastric feeding may even imply a protective effect on the intestine. To substantiate that the increases in GLP-2 reflect an intestinotropic effect of jejunal feeding, a citrulline generation test with a dipeptide alanine-glutamine drink should be performed in humans (27) .
Jejunal feeding also improves insulin secretion as was indicated by the greater peak plasma insulin concentration, which was possibly due to higher peak plasma concentrations and the iAUC of GLP-1 (28) . It is known that higher concentrations of GLP-1 may reduce glucose concentrations in critically ill patients, which leads to enhanced gastric emptying and a reduction in complications associated with insulin resistance (29) . In our healthy volunteers, glucose concentrations were similar, possibly as a result of higher insulin responses. A comparable effect has been seen in bariatric surgery in which dramatic improvements in glycemic control have been observed within 1 wk, especially after RYGB surgery. Type 2 diabetes is improved or even reversed soon after these operations and well before significant weight loss occurs (30) . This improvement is associated with a rise in GLP-1 concentrations (31) . GLP-1 is known as an incretin hormone that is responsible for part of the increase in insulin secreted after oral (opposed to intravenous) nutrient administration and, thereby, reduces fasting and postprandial glycemia (32) . In this study, we were able to create conditions that simulated nutritional administration after an RYGB. Therefore, higher concentrations of GLP-1 after jejunal feeding may improve glycemic control. During postpyloric tube feeding, gastrointestinal intolerance is observed more frequently than during prepyloric feeding, possibly by evoking a stronger gastrointestinal response. This effect was observed by Ledeboer et al. (18) , who showed that duodenal feeding elicited a stronger gastrointestinal response than that cause by gastric feeding. They showed an accelerated smallbowel transit time, more-rapid and stronger gallbladder contractions, increased cholecystokinin, and pancreatic polypeptide release. These results are comparable to our results of gastric feeding and jejunal feeding with higher peak plasma cholecystokinin concentrations being attained after jejunal feeding. Cholecystokinin is involved in the regulation of gallbladder motility, exocrine pancreas excretion through the relaxation of the sphincter of Oddi, gastric emptying, and intestinal motility (18) . Intraluminal nutrients, especially fat and protein, stimulate cholecystokinin release, which signals the pylorus to reduce gastric emptying. The apparent differences in cholecystokinin after gastric feeding and jejunal feeding may be attributed to various factors ranging from gastric emptying to the small intestine mucosa exposed to nutrients. In a previous study, we showed, with the use of labeled glucose ([6,6-2 H 2 ]glucose) that gastric emptying was less likely to attribute to the apparent differences (26) . A more-likely explanation for the increased cholecystokinin response after jejunal feeding is that nutrients were distributed over a larger area of cholecystokinin-releasing cells in the proximal small intestine.
Apart from cholecystokinin, the secretion of PYY was also significantly increased after jejunal feeding. Most effects of PYY are inhibitory, such as the inhibition of gastric, pancreatic, and intestinal secretion or reductions in gastrointestinal motility, gallbladder emptying, and gastric emptying. High concentrations of cholecystokinin and PYY are likely to contribute to delayed gastric emptying (33) . The aim of this study was to compare in vivo endocrine and exocrine responses after jejunal feeding compared with after gastric feeding with polymeric EN in healthy young men. Gastric feeding compared with jejunal feeding with EN in healthy men did not result in different postprandial plasma amino acid and glucose concentrations. The endocrine response to gastric feeding compared with to jejunal feeding differed substantially with higher peak plasma cholecystokinin, PYY, GLP-1, and GLP-2 concentrations being achieved after direct jejunal feeding. This outcome may result in an improved anabolic response, greater insulin sensitivity, and an improved intestinotropic effect. Nevertheless, it may also lead to delayed gastric emptying.
In conclusion, to our knowledge, the current study is the first to compare in vivo endocrine and exocrine responses after jejunal feeding compared with after gastric feeding in healthy young men. Noncoagulating polymeric EN resulted in similar postprandial plasma amino acid and glucose concentrations between regimens. Jejunal feeding resulted in substantially higher peak plasma cholecystokinin, PYY, GLP-1, and GLP-2 concentrations. Thus, the feeding strategy can have a distinct impact on endocrine and exocrine responses.
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